Is Vera Therapeutics, Inc. (VERA) a Buy, Sell, or Hold?
NASDAQ : VERA
Vera Therapeutics, Inc.
$42.5 USD
-$0.63 (-1.46%)
- Volume
- 1.67M
- Average Volume
- 1.58M
- Market Capitalization
- $3.05B
- P/E Ratio
- -7.67
- Dividend Yield
- 0.00%
- Price Target
- $90.00
- Year High
- $56.05
- Year Low
- $19.07
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $13.64
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
32
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
28
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$238.56K
VERA Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
VERA Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Fordyce Marshall | director, officer: PRESIDENT AND CEO | 2026-07-07 | S-Sale | 40.7762 | 2026-07-09 |
| Fordyce Marshall | director, officer: PRESIDENT AND CEO | 2026-07-07 | S-Sale | 42.0736 | 2026-07-09 |
| Fordyce Marshall | director, officer: PRESIDENT AND CEO | 2026-07-07 | S-Sale | 42.8578 | 2026-07-09 |
| Fordyce Marshall | director, officer: PRESIDENT AND CEO | 2026-07-07 | S-Sale | 43.5947 | 2026-07-09 |
| Fordyce Marshall | director, officer: PRESIDENT AND CEO | 2026-06-23 | S-Sale | 37.9311 | 2026-06-24 |
| Fordyce Marshall | director, officer: PRESIDENT AND CEO | 2026-06-23 | S-Sale | 38.43 | 2026-06-24 |
| Morrison Scott W | director | 2026-05-21 | A-Award | 34.35 | 2026-05-26 |
| Cheng Andrew | director | 2026-05-21 | A-Award | 34.35 | 2026-05-26 |
| SEIDENBERG BETH C | director | 2026-05-21 | A-Award | 34.35 | 2026-05-26 |
| Oliger Christy J. | director | 2026-05-21 | A-Award | 34.35 | 2026-05-26 |
| Meyers James R | director | 2026-05-21 | A-Award | 34.35 | 2026-05-26 |
| Hall Kimball | director | 2026-05-21 | A-Award | 34.35 | 2026-05-26 |
| MORRISSEY MICHAEL | director | 2026-05-21 | A-Award | 34.35 | 2026-05-26 |
| ENRIGHT PATRICK G | director | 2026-05-21 | A-Award | 34.35 | 2026-05-26 |
| Fordyce Marshall | director, officer: PRESIDENT AND CEO | 2026-05-12 | S-Sale | 36.6396 | 2026-05-13 |
| Fordyce Marshall | director, officer: PRESIDENT AND CEO | 2026-05-12 | S-Sale | 37.0868 | 2026-05-13 |
| Fordyce Marshall | director, officer: PRESIDENT AND CEO | 2026-04-14 | S-Sale | 43.6649 | 2026-04-15 |
| Fordyce Marshall | director, officer: PRESIDENT AND CEO | 2026-04-14 | S-Sale | 44.5784 | 2026-04-15 |
| Fordyce Marshall | director, officer: PRESIDENT AND CEO | 2026-04-14 | S-Sale | 45.5114 | 2026-04-15 |
| Wright-Mitchell Jane | officer: Chief Legal Officer | 2026-03-23 | A-Award | 40.73 | 2026-03-25 |
| Wright-Mitchell Jane | officer: Chief Legal Officer | 2026-03-23 | A-Award | 0 | 2026-03-25 |
| Wright-Mitchell Jane | 2026-03-23 | 0 | 2026-03-25 | ||
| Young Joseph R | officer: SVP, FINANCE, CHIEF ACCT OFFCR | 2026-03-13 | M-Exempt | 3.9396 | 2026-03-16 |
| Young Joseph R | officer: SVP, FINANCE, CHIEF ACCT OFFCR | 2026-03-13 | M-Exempt | 3.9396 | 2026-03-16 |
| Hite Christopher | director | 2026-03-05 | A-Award | 38.85 | 2026-03-09 |
| Hite Christopher | 2026-03-05 | 0 | 2026-03-09 | ||
| Brenner Robert | officer: Chief Medical Officer | 2026-02-23 | S-Sale | 41.9839 | 2026-02-25 |
| Young Joseph R | officer: SVP, FINANCE, CHIEF ACCT OFFCR | 2026-02-23 | S-Sale | 41.9839 | 2026-02-25 |
| Grant Sean | officer: CHIEF FINANCIAL OFFICER | 2026-02-23 | S-Sale | 41.9839 | 2026-02-25 |
| Fordyce Marshall | director, officer: PRESIDENT AND CEO | 2026-02-23 | S-Sale | 41.9839 | 2026-02-25 |
| JOHNSON DAVID LEE | officer: Chief Operating Officer | 2026-02-23 | S-Sale | 41.9839 | 2026-02-25 |
| Turner William D. | officer: Chief Regulatory Officer | 2026-02-23 | S-Sale | 41.9839 | 2026-02-25 |
| Skelton Laurence Matthew | officer: Chief Commercial Officer | 2026-02-23 | S-Sale | 41.9839 | 2026-02-25 |
| Young Joseph R | officer: SVP, FINANCE, CHIEF ACCT OFFCR | 2026-02-04 | A-Award | 0 | 2026-02-06 |
| Young Joseph R | officer: SVP, FINANCE, CHIEF ACCT OFFCR | 2026-02-04 | A-Award | 42.74 | 2026-02-06 |
| Fordyce Marshall | director, officer: PRESIDENT AND CEO | 2026-02-04 | A-Award | 0 | 2026-02-06 |
| Fordyce Marshall | director, officer: PRESIDENT AND CEO | 2026-02-04 | A-Award | 42.74 | 2026-02-06 |
| Grant Sean | officer: CHIEF FINANCIAL OFFICER | 2026-02-04 | A-Award | 0 | 2026-02-06 |
| Grant Sean | officer: CHIEF FINANCIAL OFFICER | 2026-02-04 | A-Award | 42.74 | 2026-02-06 |
| Skelton Laurence Matthew | officer: Chief Commercial Officer | 2026-02-04 | A-Award | 0 | 2026-02-06 |
| Skelton Laurence Matthew | officer: Chief Commercial Officer | 2026-02-04 | A-Award | 42.74 | 2026-02-06 |
| Turner William D. | officer: Chief Regulatory Officer | 2026-02-04 | A-Award | 42.74 | 2026-02-06 |
| Turner William D. | officer: Chief Regulatory Officer | 2026-02-04 | A-Award | 0 | 2026-02-06 |
| JOHNSON DAVID LEE | officer: Chief Operating Officer | 2026-02-04 | A-Award | 0 | 2026-02-06 |
| JOHNSON DAVID LEE | officer: Chief Operating Officer | 2026-02-04 | A-Award | 42.74 | 2026-02-06 |
| Brenner Robert | officer: Chief Medical Officer | 2026-02-04 | A-Award | 0 | 2026-02-06 |
| Brenner Robert | officer: Chief Medical Officer | 2026-02-04 | A-Award | 42.74 | 2026-02-06 |
| Skelton Laurence Matthew | officer: Chief Commercial Officer | 2026-01-20 | 0 | 2026-01-30 | |
| Skelton Laurence Matthew | officer: Chief Commercial Officer | 2026-01-20 | 0 | 2026-01-30 | |
| Skelton Laurence Matthew | officer: Chief Commercial Officer | 2026-01-20 | 41.75 | 2026-01-30 | |
| Skelton Laurence Matthew | officer: Chief Commercial Officer | 2026-01-20 | 29.18 | 2026-01-30 | |
| Turner William D. | officer: Chief Regulatory Officer | 2025-12-15 | M-Exempt | 15.53 | 2025-12-17 |
| Turner William D. | officer: Chief Regulatory Officer | 2025-12-15 | M-Exempt | 15.53 | 2025-12-17 |
| Turner William D. | officer: Chief Regulatory Officer | 2025-12-15 | S-Sale | 50.0767 | 2025-12-17 |
| ENRIGHT PATRICK G | director | 2025-12-11 | P-Purchase | 42.5 | 2025-12-15 |
| Turner William D. | officer: Chief Regulatory Officer | 2025-12-08 | M-Exempt | 15.53 | 2025-12-10 |
| Turner William D. | officer: Chief Regulatory Officer | 2025-12-08 | M-Exempt | 15.53 | 2025-12-10 |
| Turner William D. | officer: Chief Regulatory Officer | 2025-12-08 | S-Sale | 45.3053 | 2025-12-10 |
| Turner William D. | officer: Chief Regulatory Officer | 2025-12-03 | M-Exempt | 15.53 | 2025-12-04 |
| Turner William D. | officer: Chief Regulatory Officer | 2025-12-03 | M-Exempt | 15.53 | 2025-12-04 |
| Turner William D. | officer: Chief Regulatory Officer | 2025-12-03 | S-Sale | 40 | 2025-12-04 |
| Meyers James R | director | 2025-11-25 | A-Award | 29.43 | 2025-11-26 |
| Meyers James R | 2025-11-25 | 0 | 2025-11-26 | ||
| Carter Jason S | officer: Chief Legal Officer | 2025-11-21 | S-Sale | 27.8204 | 2025-11-25 |
| Young Joseph R | officer: SVP, FINANCE, CHIEF ACCT OFFCR | 2025-11-13 | M-Exempt | 3.9396 | 2025-11-13 |
| Young Joseph R | officer: SVP, FINANCE, CHIEF ACCT OFFCR | 2025-11-13 | M-Exempt | 3.9396 | 2025-11-13 |
| Young Joseph R | officer: SVP, FINANCE, CHIEF ACCT OFFCR | 2025-11-11 | S-Sale | 29.0583 | 2025-11-13 |
| ENRIGHT PATRICK G | director | 2025-06-24 | P-Purchase | 22.3517 | 2025-06-25 |
| ENRIGHT PATRICK G | director | 2025-06-23 | P-Purchase | 20.8683 | 2025-06-25 |
| ENRIGHT PATRICK G | director | 2025-06-24 | P-Purchase | 22.3517 | 2025-06-25 |
| ENRIGHT PATRICK G | director | 2025-06-23 | P-Purchase | 20.8683 | 2025-06-25 |
| Katabi Maha | director | 2025-05-14 | A-Award | 21.19 | 2025-05-16 |
| ENRIGHT PATRICK G | director | 2025-05-14 | A-Award | 21.19 | 2025-05-16 |
| Oliger Christy J. | director | 2025-05-14 | A-Award | 21.19 | 2025-05-16 |
| MORRISSEY MICHAEL | director | 2025-05-14 | A-Award | 21.19 | 2025-05-16 |
| SEIDENBERG BETH C | director | 2025-05-14 | A-Award | 21.19 | 2025-05-16 |
| Hall Kimball | director | 2025-05-14 | A-Award | 21.19 | 2025-05-16 |
| Morrison Scott W | director | 2025-05-14 | A-Award | 21.19 | 2025-05-16 |
| Cheng Andrew | director | 2025-05-14 | A-Award | 21.19 | 2025-05-16 |
| Fordyce Marshall | director, officer: PRESIDENT AND CEO | 2025-02-21 | S-Sale | 27.8933 | 2025-02-27 |
| Fordyce Marshall | director, officer: PRESIDENT AND CEO | 2025-02-26 | S-Sale | 27.5526 | 2025-02-27 |
| Fordyce Marshall | director, officer: PRESIDENT AND CEO | 2025-02-26 | S-Sale | 28.3183 | 2025-02-27 |
| Young Joseph R | officer: SVP, FINANCE, CHIEF ACCT OFFCR | 2025-02-18 | A-Award | 0 | 2025-02-20 |
| Young Joseph R | officer: SVP, FINANCE, CHIEF ACCT OFFCR | 2025-02-18 | A-Award | 29.18 | 2025-02-20 |
| Turner William D. | officer: Chief Development Officer | 2025-02-18 | A-Award | 29.18 | 2025-02-20 |
| Turner William D. | officer: Chief Development Officer | 2025-02-18 | A-Award | 0 | 2025-02-20 |
| Brenner Robert | officer: Chief Medical Officer | 2025-02-18 | A-Award | 29.18 | 2025-02-20 |
| Brenner Robert | officer: Chief Medical Officer | 2025-02-18 | A-Award | 0 | 2025-02-20 |
| Grant Sean | officer: CHIEF FINANCIAL OFFICER | 2025-02-18 | A-Award | 0 | 2025-02-20 |
| Grant Sean | officer: CHIEF FINANCIAL OFFICER | 2025-02-18 | A-Award | 29.18 | 2025-02-20 |
| Fordyce Marshall | director, officer: PRESIDENT AND CEO | 2025-02-18 | A-Award | 0 | 2025-02-20 |
| Fordyce Marshall | director, officer: PRESIDENT AND CEO | 2025-02-18 | A-Award | 29.18 | 2025-02-20 |
| JOHNSON DAVID LEE | officer: Chief Operating Officer | 2025-02-18 | A-Award | 29.18 | 2025-02-20 |
| JOHNSON DAVID LEE | officer: Chief Operating Officer | 2025-02-18 | A-Award | 0 | 2025-02-20 |
| Fordyce Marshall | director, officer: PRESIDENT AND CEO | 2025-01-08 | M-Exempt | 2.8968 | 2025-01-10 |
| Fordyce Marshall | director, officer: PRESIDENT AND CEO | 2025-01-08 | M-Exempt | 2.8968 | 2025-01-10 |
| Fordyce Marshall | director, officer: PRESIDENT AND CEO | 2025-01-08 | M-Exempt | 2.8968 | 2025-01-10 |
| Fordyce Marshall | director, officer: PRESIDENT AND CEO | 2025-01-08 | M-Exempt | 2.8968 | 2025-01-10 |
| Fordyce Marshall | director, officer: PRESIDENT AND CEO | 2025-01-08 | M-Exempt | 2.8968 | 2025-01-10 |
| Fordyce Marshall | director, officer: PRESIDENT AND CEO | 2025-01-08 | S-Sale | 42 | 2025-01-10 |